Arrowhead Pharmaceuticals, Inc. Share Price

Arrowhead Pharmaceuticals, Inc. Share Price

NASDAQ: ARWR | Mid Cap
$61.59
+$1.40 (2.33%) Last updated on 29 Oct, 2026 | 19:57 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Arrowhead Pharmaceuticals, Inc. Stock Performance

Open
$60.63
Prev. Close
$60.19
Circuit Range
N/A
Day Range
$60.63 - $61.83
Year Range
$37.14 - $95.39
Volume
16,182
Average Traded
$61.50

Arrowhead Pharmaceuticals, Inc. Share Price Today

As of 29 October 2026, Arrowhead Pharmaceuticals, Inc.'s share price is $61.59. The stock opened at $60.63, compared to its previous close of $60.19. During today's trading session, Arrowhead Pharmaceuticals, Inc.'s share price traded between $60.63 and $61.83, with an average price of $61.23. Over the past 52 weeks, the stock has recorded a high of $95.39 and a low of $37.14. In terms of performance, Arrowhead Pharmaceuticals, Inc.'s share price has declined by 16.19% over the last six months and is up 45.24% on a year-on-year basis.

Arrowhead Pharmaceuticals, Inc. Share Price Chart

Line chart of the Arrowhead Pharmaceuticals, Inc. price trend over the selected period. The price rose overall, ranging from 60.63 to 61.77, ending at 61.59.
$60.63$61.83
L
Show Current Price
H

Arrowhead Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$8.24B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.27
Revenue (TTM)
$829.45B
Return On Equity (TTM)
-68.73%
Profit Margin
-0.20%
Debt to Equity
1.86
Quarterly Earnings Growth YoY
-718.02%

Arrowhead Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$256.47$264.03$73.74$75.25
Net Profit-$23.75$30.81-$132.73-$194.28
Net Profit Margin-9.26%11.67%-180.00%-258.18%
Income ChangeN/A229.73%-530.80%-46.37%

Arrowhead Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$243.23$240.74$3.55$829.45
Net Profit-$176.06-$205.28-$599.49-$1.63
Net Profit Margin-72.38%-85.27%-16887.04%-0.20%
Income ChangeN/A-16.60%-192.04%99.73%

About Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals Inc is a commercial-stage pharmaceutical company. It is focused on the development of medicines for diseases associated with genetic abnormalities or protein overproduction. The company develops potential RNAi therapies designed to inhibit the expression of genes known to trigger diseases. Its portfolio includes potential drugs targeting Cardiometabolic, Neuromuscular, Pulmonary, Liver, and other diseases. The company also develops RNAi products and clinical candidates designed to target different cell types within the body.

Arrowhead Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$64.94
$61.72
-5.82%
Sep 2026
$81.25
$65.53
-26.07%
Aug 2026
$84.81
$88.65
+4.74%
Jul 2026
$80.56
$84.64
+3.85%
Jun 2026
$75.95
$81.50
+4.54%
May 2026
$74.40
$77.96
+6.08%
Apr 2026
$63.35
$73.49
+17.20%
Mar 2026
$61.50
$62.70
-0.85%
Feb 2026
$68.70
$63.24
-8.76%
Jan 2026
$66.47
$69.31
+4.42%
Dec 2025
$53.89
$66.38
+26.01%
Nov 2025
$41.83
$52.68
+24.23%

ARWR Share Price FAQs